Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kurashiki
Clinical trial register · Japan

Clinical Trials in Kurashiki, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Kurashiki

24 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Metagen Therapeutics, Inc.
Phase 1/2
54
Fukuoka, Sapporo, Kurashiki, Hirakata, Hamamatsu, Bunkyō-Ku, Minato-Ku, Mitaka
2026-07-09
Recruiting
Sun Pharma Japan Limited
Phase 3
78
Asahikawa, Bunkyō City, Ebina, Hamamatsu, Ishikawa, Kitakyushu, Kōtoku, Kurashiki
2026-06-19
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals
Phase 3
460
Toyoake, Kamogawa, Sapporo, Kobe, Shiwa-Gun, Tsu, Kurashiki, Bunkyo Ku
2026-05-27
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies, Amyloid
Eli Lilly and Company
Phase 2
350
Bunkyō City, Fujisawa, Himeji, Inage, Kawasaki, Kobe, Kōtoku, Kurashiki
2026-05-20
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Nagoya, Chiba, Kashiwa, Matsuyama, Yokohama, Kurashiki, Osaka, Suita
2026-03-13
Recruiting
AbbVie
Observational
700
Maebashi, Asahikawa-shi, Sapporo, Kagoshima, Isehara, Yokohama, Kyoto, Kurashiki
2025-09-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2
340
Ōbu, Narashino, Kawasaki, Tsu, Kurashiki, Hirakata, Kanzaki-gun, Shinjuku
2025-07-16
Recruiting
Aveir Leadless Pacemaker Japan PMS
NCT07106788Leadless Pacemaker
Abbott Medical Devices
Observational
304
Nagoya, Kitakyushu, Kawasaki, Sendai, Kurashiki, Hirakata, Osaka, Suita
2025-05-26
Recruiting
Dianthus Therapeutics
Phase 3
256
Niigata, Kawasaki, Tsukuba, Kurashiki, Hirakata, Kawagoe, Ube, Chiba
2025-02-10
Recruiting
UCB Biopharma SRL
Phase 3
450
Bunkyō City, Chūōku, Fukuoka, Kawagoe, Kawasaki-shi, Kita-gun, Kitakyushu, Kurashiki
2024-11-21
Active, closed
Eisai Inc.
Phase 2
105
Ōbu, Ōtake, Honjō, Kurashiki, Shinjuku, Osaka, Yamagata
2024-09-30
Active, closed
AbbVie
Phase 3
184
Ichinomiya, Marugame, Kyoto, Kurashiki, Mibu, Suginami-Ku, Tachikawa-shi, Kofu
2024-06-14
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Nagoya, Kitakyushu, Sapporo, Yokohama, Kuwana, Sasebo, Kurashiki, Bunkyo Ku
2023-10-27
Active, closed
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
NCT05831176Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis
Regeneron Pharmaceuticals
Phase 2
22
Iizuka, Ōgaki, Kure, Himeji, Kobe, Yokohama, Kurashiki, Minato-ku
2023-05-03
Active, closed
Kringle Pharma, Inc.
Phase 3
62
Toyoake, Fukuoka, Kurume, Kamigyō-ku, Sendai, Kurashiki, Chiyoda-ku, Minato-Ku
2022-12-01
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Chūōku, Himeji, Hirakata, Kanagawa, Kurashiki, Kurume, Matsusaka, Niigata
2022-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Nagoya, Kitakyushu, Sapporo, Yokohama, Kuwana, Sasebo, Kurashiki, Bunkyo Ku
2022-08-04
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 3
405
Nagoya, Toyoake, Sapporo, Kobe, Kurashiki, Sakai, Suita, Shimotsuke
2021-10-06
Active, closed
Ono Pharmaceutical Co., Ltd.
Phase 1
65
Toyoake, Chiba, Kashiwa, Sapporo, Kobe, Kawasaki, Yokohama, Kurashiki
2021-09-23
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Chiba, Fukuoka, Gifu, Hokkaido, Kobe, Koshigaya, Kumamoto, Kurashiki
2021-02-01
Recruiting
Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer
NCT06490159Gastric Cancer, Chemotherapy-induced Peripheral Neuropathy, Paclitaxel, Ramucirumab
City of Hope Medical Center
Observational
150
Kurashiki
2018-10-01
Recruiting
Japanese CTO PCI Expert Registry
NCT01889459Chronic Total Occlusion of Coronary Artery
Kurashiki Central Hospital
Observational
19,000
Kurashiki
2013-07
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-japan/city/kurashiki

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Kurashiki.

How many clinical trials are recruiting in Kurashiki?

13 of the 24 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kurashiki), 24 studies
PhaseStudiesRecruitingShare
Phase 312450%
Phase 25320.8%
Observational4416.7%
Phase 1104.2%
Phase 1/2114.2%
Phase 2/3114.2%

Most active sponsors

Lead sponsors with the most studies (Kurashiki)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals41
Merck Sharp & Dohme LLC31
AbbVie21
Janssen Research & Development, LLC21
Abbott Medical Devices11
Bristol-Myers Squibb11
City of Hope Medical Center11
Dianthus Therapeutics11
Eisai Inc.10
Eli Lilly and Company11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.